Article: The Pathologist – Advancing prostate cancer diagnostics​

Increased public awareness and concerning statistics highlight the urgent need for improved prostate cancer testing, as the current PSA test is inaccurate, expensive, and often detects the disease too late. The development of a more accurate, non-invasive, and rapid urine-based lateral flow test using biomarkers offers a promising solution for earlier detection and improved patient outcomes. Read the article in full on The Pathologist here.